| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |